Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 49 min ago
PreprintAll rights reservedbioRxiv

LIPC-E97G Gain-of-function variant potentiates the hypocholesterolemic and anti-atherogenic effects of evinacumab in Ldlr-/- mice

  • L. vince
  • A. Thouzeau
  • A. Ayer
  • B. Cariou
  • A. Rimbert
  • C. Le May1
  1. 1L'Institut du Thorax, INSERM, CNRS, UNIV Nantes
Read full textPDFDOICite

Related

  1. Association of Visceral Adiposity, Core Skeletal Muscle Mass, Atherogenic Index of Plasma, and Renal Function (CKD-EPI) with Framingham Cardiovascular Risk Score in Adults: A Cross-Sectional Study
    Nathanael Ryan Hansel Wijaya, Ronald Winardi Kartika, Andria Priyana +1
    Majalah Kardiologi IndonesiaPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  2. Genome-Wide Association Study of Sepsis Susceptibility in ICU Patients Identifies Arab Founder Loss-of-Function Variant in UBE2L3
    M. R. Rostami, A. Ait Hssain, A. Robay +4
    medRxivPreprintAll rights reservedFull textHuman geneticsmedRxiv
  3. CO059 | EXTRACELLULAR VESICLES AS BIOMARKERS IN FAMILIAL HYPERCHOLESTEROLEMIAS TREATED WITH EVINACUMAB
    Chiara Sama'
    Bleeding, Thrombosis and Vascular BiologyPeer-reviewedCC BY-NCFull textCardiovascular medicineDOAJ
  4. Factor VIII Aurora: A Naturally Occurring Gain of Function FVIII Variant with Enhanced FIXa Affinity
    Johnathan J. Morris, Robert J. Davidson, Connor T. Watson +1
    BloodPeer-reviewedCC BY-NC-NDFull textGeneral medicinePMC
  5. Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy
    Yuta Yamamoto, Kaiser Chua, David Staudt +24
    CirculationPeer-reviewedCC BY-NC-ND 4.0Full text4 citedCardiovascular medicinePMC

Cite

BibTeXRIS
BibTeX
@misc{vince2026lipce97g,
  title = {{LIPC-E97G Gain-of-function variant potentiates the hypocholesterolemic and anti-atherogenic effects of evinacumab in Ldlr-/- mice}},
  author = {L. vince and A. Thouzeau and A. Ayer and B. Cariou and A. Rimbert and C. Le May},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.28.754893},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.28.754893v1},
}
RIS
TY  - UNPB
TI  - LIPC-E97G Gain-of-function variant potentiates the hypocholesterolemic and anti-atherogenic effects of evinacumab in Ldlr-/- mice
AU  - L. vince
AU  - A. Thouzeau
AU  - A. Ayer
AU  - B. Cariou
AU  - A. Rimbert
AU  - C. Le May
PY  - 2026
DA  - 2026/09/28
PB  - bioRxiv
DO  - 10.64898/2026.09.28.754893
UR  - https://www.biorxiv.org/content/10.64898/2026.09.28.754893v1
ER  -